课题基金 / 基金详情

Immune Modulatory Nanofibers for Skeletal Muscle Reconstruction

Immune Modulatory Nanofibers for Skeletal Muscle Reconstruction
用于骨骼肌重建的免疫调节纳米纤维
批准号:
9565183
负责人:
Edward A. Botchwey
金额:
$39.45万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-18 至 2019-08-31
关键词:
AddressAdoptive TransferAgingAgonistAnti-Inflammatory AgentsAnti-inflammatoryApoptoticArticular Range of MotionBehaviorBiocompatible MaterialsBiological AssayBloodBlood VesselsCaliberCell CommunicationCell MaintenanceCell ProliferationCellsClinicalDefectDepositionDorsal Skinfold Window Chamber ModelDoseElderlyEndotheliumEngineeringEnvironmental Risk FactorExhibitsFiberFibrosisFlow CytometryFunctional disorderGenetic ModelsGrowthGrowth FactorHistologicHumanImmuneImmune responseImmunologicsImpaired wound healingImplantInfiltrationInflammationInflammatoryInflammatory InfiltrateInjuryKineticsLipidsMeasuresMetabolicMetabolismMicrovascular DysfunctionModelingMononuclearMorphologyMusMuscleMuscle FibersMuscle satellite cellMuscular AtrophyMyeloid CellsNeuromuscular JunctionOperative Surgical ProceduresOutcomePainPaperPathologic ProcessesPatient-Focused OutcomesPhagocytesPharmaceutical PreparationsPharmacologyPolymersPopulationPre-Clinical ModelPreventionProteinsPublishingRANTESRecoveryRecovery of FunctionRecruitment ActivityRecurrenceResearchResolutionRestShoulder PainSignal TransductionSkeletal MuscleSkeletal muscle injurySourceSpatial DistributionSphingosine-1-Phosphate ReceptorSymptomsSystemTNF geneTherapeuticTimeTissuesTraumaVascularizationWorkWound Healingangiogenesisbasecostcytokinedisabilityexperimental studyfunctional outcomeshealingimprovedin vivoinjuredinnovationliquid chromatography mass spectrometrymacrophagemonocytemouse modelmuscle degenerationnanofibernerve transectionprogenitorquadriceps musclereceptorreconstructionregenerativerepairedresponserotator cuff tearsatellite cellscaffoldsmall moleculesphingosine 1-phosphatestemtool

项目摘要

项目成果

Edward A. Botchwey的其他基金

相似基金

相关文献

中文摘要
翻译
抽象/项目总结
英文摘要
Abstract/Project Summary Severe skeletal muscle trauma resulting from ischemic damage, nerve transection injuries, or volumetric defects is an intractable problem. Dysfunction and disability owing to the latter are an increasingly significant clinical burden. To address this challenge, this proposal seeks to develop biomaterial delivery systems that regulate the micro-environmental factors that harness the pro-regenerative functions of recruited blood monocytes to enhance volumetric muscle healing outcomes. In a pre-clinical model of volumetric muscle loss, we have shown that delivery of immune modulatory small molecules targeted to bioactive lipid receptors increases wound repair macrophages within the injury niche and enhances repair mechanisms such as angiogenesis, matrix deposition, and muscle fiber regrowth. The overall hypothesis for the proposed research is that local pharmacological targeting of sphingosine 1-phosphate (S1P) receptors uniquely recruits Ly6Clo monocytes directly from blood to the injury niche where they serve as biased progenitors of wound healing macrophages within injured muscle. Our specific aims are as follows: Aim 1: To characterize inflammatory infiltrate into the murine spinotrapezius volumetric muscle loss model and immune cell interactions with muscle satellite cells; Aim 2: To assess the impact of local delivery of S1P receptor targeted small molecules from polymer scaffolds on myeloid cell accumulation and behavior after skeletal muscle injury; Aim 3: To evaluate functional outcomes within a critical-sized volumetric defect in the murine quadriceps in response to local delivery of S1P receptor targeted small molecules. As the sequelae of muscle injuries increases at a disproportionate rate with advancing age, the burden of muscle injury on an aging domestic population will be increasingly severe. Thud, mechanisms surrounding the healing of volumetric muscle defects must be elucidated in order to advance translational therapeutics.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
T32 CTEng (Cellular and Tissue Engineering) Training Program
  • 批准号:
    10641891
  • 项目类别:
  • 资助金额:
    $47.75万
  • 财政年份:
    2022
  • 负责人:
    Edward A. Botchwey
  • 依托单位:
T32 CTEng (Cellular and Tissue Engineering) Training Program
  • 批准号:
    10420388
  • 项目类别:
  • 资助金额:
    $46.83万
  • 财政年份:
    2022
  • 负责人:
    Edward A. Botchwey
  • 依托单位:
Artery biomechanics and vascular damage in sickle cell disease
  • 批准号:
    10390381
  • 项目类别:
  • 资助金额:
    $58.09万
  • 财政年份:
    2021
  • 负责人:
    Edward A. Botchwey
  • 依托单位:
Artery biomechanics and vascular damage in sickle cell disease
  • 批准号:
    10606485
  • 项目类别:
  • 资助金额:
    $56.41万
  • 财政年份:
    2021
  • 负责人:
    Edward A. Botchwey
  • 依托单位:
海外基金